BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17545501)

  • 1. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
    Nan Luo ; Johnson JA; Shaw JW; Coons SJ
    Med Decis Making; 2007; 27(3):321-6. PubMed ID: 17545501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
    Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
    Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):401-9. PubMed ID: 16855128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.
    Kiadaliri AA
    Int J Health Policy Manag; 2017 May; 6(5):267-272. PubMed ID: 28812814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic mapping of the health status measure SF-12 onto the health utility measure EQ-5D using the US-population-based scoring models.
    Le QA
    Qual Life Res; 2014 Mar; 23(2):459-66. PubMed ID: 24026631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
    Shaw JW; Johnson JA; Coons SJ
    Med Care; 2005 Mar; 43(3):203-20. PubMed ID: 15725977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China.
    Zhang RY; Wang W; Zhou HJ; Xuan JW; Luo N; Wang P
    Health Qual Life Outcomes; 2022 May; 20(1):80. PubMed ID: 35590333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Empirical research of measuring elderly health utility in the outskirts of Beijing by using European quality of life 5-dimensions].
    Wu YQ; Liu K; Tang X; Cao Y; Wang JW; Li N; Liu JJ; Yu LP; Xu HT; Liu WJ; Wen SS; Hu YH; Li K
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):397-402. PubMed ID: 22692310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A median model for predicting United States population-based EQ-5D health state preferences.
    Shaw JW; Pickard AS; Yu S; Chen S; Iannacchione VG; Johnson JA; Coons SJ
    Value Health; 2010; 13(2):278-88. PubMed ID: 19961566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.